BioSmart Co.Ltd (038460) — Capital Reinvestment Ratio
BioSmart Co.Ltd (038460) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.59 Billion) in capital expenditures (₩1.22 Billion). Check how tangible is BioSmart Co.Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BioSmart Co.Ltd Capital Reinvestment Ratio (2010–2024)
This chart tracks BioSmart Co.Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BioSmart Co.Ltd.
Annual Capital Reinvestment Ratio for BioSmart Co.Ltd (2010–2024)
Year-by-year Capital Reinvestment Ratio for BioSmart Co.Ltd from 2010 to 2024. See 038460 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.28x | ₩3.80 Billion | ₩8.66 Billion | ▼ -45.9% |
| 2023 | 4.22x | ₩1.17 Billion | ₩4.92 Billion | ▲ +301.7% |
| 2022 | 1.05x | ₩5.59 Billion | ₩5.87 Billion | ▼ -75.8% |
| 2021 | 4.34x | ₩1.20 Billion | ₩5.22 Billion | ▲ +656.0% |
| 2018 | 0.57x | ₩5.81 Billion | ₩3.34 Billion | ▼ -19.1% |
| 2014 | 0.71x | ₩1.31 Billion | ₩927.27 Million | ▲ +265.3% |
| 2013 | 0.19x | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩4.76 Billion | ₩589.05 Million | — |